Q2 2025 Earnings Call Transcript July 16, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.77, ...

Livzon Mabpharm Inc.’s anti-IL-17A/F monoclonal antibody, LZM-012, met the primary endpoint in a phase III trial in moderate to severe plaque psoriasis. Conducted at Fudan University’s Huashan ...

Early intervention with IL-17 inhibitors among patients with plaque psoriasis is associated with improved relapse and remission rates.

The likelihood of reduced quality of life and high symptom burden in patients with psoriasis was similar across those with low, medium, and high BSA.

Medically reviewed by Angela Ryan Lee, MD Atherosclerosis is a condition where plaque (fatty deposits) builds up inside your arteries, causing them to become stiff and narrow. This can slow or block ...

SMX gains national spotlight as key player in securing defense supply chains – media recognition signals growing market relevance NEW YORK, NY / ACCESS Newswire / July 21, 2025 / A recent editorial ...